North America was the major shareholder in 2022. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period. PO ...

More than 40 drugs are now available to treat HIV infection Medically reviewed by Lindsay Cook, PharmD Fact checked by Sarah Scott Antiretroviral drugs are used to treat HIV infection. They work ...

In the second trial, which was open label, 95.6% of participants who switched to DOR/ISL maintained viral suppression ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

After Gilead Sciences' lenacapavir made waves with stellar clinical results as a twice-yearly HIV prevention candidate, the ...

that are currently approved by the Food and Drug Administration (FDA) to treat HIV. Many different classes of antiretroviral drugs are used to treat HIV. A healthcare professional will assess a ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

used in combination antiretroviral therapy, is effective and safe for heavily treatment-experienced patients with multidrug-resistant HIV. Data from the study were presented at the 2025 Conference ...

Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months.